Characteristics | Patients with implant n = 88 | Patients without implant n = 14 | P-value |
---|---|---|---|
Age (years), median (range) | 66.5 (30–89) | 68.5 (47–82) | 0.556 |
Gender, n (%) | 0.214 | ||
Male | 54 (61.4) | 11 (78.6) | |
Female | 34 (38.6) | 3 (21.4) | |
Event, n (%) | 0.240 | ||
Stroke | 80 (90.9) | 14 (100) | |
Transient ischemic attack | 8 (9.1) | 0 | |
Body mass index (kg/m2), median (range) | 27 (19–49) | 28 (20–34) | 0.995 |
Comorbidity, n (%) | |||
Hypertension | 59 (67.0) | 10 (71.4) | 0.745 |
Diabetes mellitus | 20 (22.7) | 2 (14.3) | 0.476 |
Vasculopathy | 19 (21.6) | 1 (7.1) | 0.206 |
Heart failure | 3 (3.4) | 0 | 0.483 |
CHA2DS2-VASc score, median (range) | 4 (2–7) | 4.5 (2–7) | 0.870 |
Score 2, n (%) | 7 (8.0) | 2 (14.3) | |
Score 3, n (%) | 20 (22.7) | 3 (21.4) | |
Score 4, n (%) | 19 (21.6) | 2 (14.3) | |
Score 5, n (%) | 22 (25.0) | 2 (14.3) | |
Score 6, n (%) | 11 (12.5) | 3 (21.4) | |
Score 7, n (%) | 9 (10.2) | 2 (14.3) | |
Extrasystole, n (%) | 64 (72.7) | 0 | |
Number of drugs, median (range) | 4 (1–14) | 5 (2–10) | 0.709 |
Smocking status, n (%) | 0.069 | ||
Nonsmoker | 49 (55.7) | 8 (57.1) | |
Smoker | 25 (28.4) | 1 (7.1) | |
Ex-smoker | 12 (13.6) | 3 (21.4) | |
No indication | 2 (2.3) | 2 (14.3) |